Location History:
- Marseille, FR (2000 - 2001)
- Marseilles, FR (2003 - 2011)
Company Filing History:
3 out of 1,829 
2 out of 1,744 
1 out of 28 Years Active: 2000-2011
Title: Pierre Golstein: Innovator in Monoclonal Antibodies
Introduction
Pierre Golstein is a prominent inventor based in Marseilles, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to his name, Golstein's work has advanced the understanding and application of human CTLA-8.
Latest Patents
Golstein's latest patents include groundbreaking innovations such as monoclonal antibodies to human CTLA-8 (IL-17A). These patents encompass human CTLA-8 protein, antibodies that specifically bind to human CTLA-8, and nucleic acids encoding human CTLA-8. Additionally, methods of using these molecules and diagnostic kits are provided. Another notable patent involves nucleic acids encoding CTLA-8 and related reagents, including CTLA-8 antigen from a mammal, purified proteins, specific antibodies, and nucleic acids encoding said antigen. Methods of using these reagents and diagnostic kits are also included in his patents.
Career Highlights
Throughout his career, Golstein has worked with notable companies, including Schering Corporation. His expertise in the field has led to significant advancements in therapeutic applications and diagnostic tools.
Collaborations
Golstein has collaborated with esteemed colleagues such as Eric Rouvier and Francois Fossiez. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Pierre Golstein's contributions to the field of biotechnology, particularly in monoclonal antibodies, have had a lasting impact. His innovative patents and collaborations highlight his role as a key figure in advancing medical science.